PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Early evidence suggests hybrid cochlear implants may benefit millions with common form of hearing loss

Multicenter study led by NYU Langone Medical Center shows that device leads to major improvements in hearing and speech recognition

2015-07-28
(Press-News.org) People with a common form of hearing loss not helped by hearing aids achieved significant and sometimes profound improvements in their hearing and understanding of speech with hybrid cochlear implant devices, according to a new multicenter study led by specialists at NYU Langone Medical Center.

In the study, described online ahead of print in the journal The Laryngoscope July 7, researchers at 10 medical centers and private clinics in the United States implanted hybrid cochlear implants into one ear of 50 men and women. All study volunteers had badly damaged high-frequency, inner-ear hair cells, which prevented them from understanding speech, especially in the presence of background noise. All still had sufficient low-frequency hearing, which allowed them to tell apart some sounds and forestalled any use of a regular cochlear implant.

A year after receiving the device, 45 study participants showed overall improvement in their hearing and speech recognition, and no one's hearing and speech recognition got worse.

"Our study offers early evidence that potentially millions more people with high-frequency hearing loss, who cannot benefit from a hearing aid, could instead possibly benefit from a hybrid cochlear implant," says lead study investigator J. Thomas Roland, MD, the Mendik Foundation Chairman of the Department of Otolaryngology-Head and Neck Surgery at NYU Langone. Roland, who also serves as co-director of NYU Langone's cochlear implant program, has nearly 30 years of experience in research and caring for people with the devices, which were first approved for use in the United States in 1984, and he has installed many hybrid implants, which were approved for adults by the US Food and Drug Administration in 2014.

The hybrid implant differs from the traditional device in that it has a shorter electrode (less than 2 centimeters long) that does not have to be inserted as deeply into the spiral-shaped sensory structure (the cochlea) in the inner ear. When placed correctly, the technique preserves more residual, natural, low-frequency hearing and augments high-frequency hearing with electrical stimulation.

The National Institute on Deafness and Other Communication Disorders estimates that some 26 million American adults between the ages of 20 and 69 suffer from some loss of high-frequency hearing, which makes speech recognition especially difficult.

According to Roland, the loss of high-frequency hearing had left all study participants "in a difficult spot." Many were failing at work and in social environments because of their inability to hear and understand speech.

Roland says hearing aids were not an option for them because the sound-amplifying tools cannot sufficiently raise high-frequency sounds to improve understanding of speech, especially when there is any kind of background noise.

Roland also says the study participants had "too much residual hearing to lose," so having traditional cochlear implants -- one in each ear to replace both high- and low-frequency hearing -- was not an optimal option (although five study participants did eventually choose this route.)

Among the study participants, 15 with total loss of high-frequency hearing and moderate loss of low-frequency hearing saw improvements in standard tests of their ability to understand set phrases and sentences read back to them. Their scores for correctly identifying spoken words and phrases rose from a baseline average of 21 percent before implantation to 67 percent a year after implantation and activation of their device.

For 14 other study participants with severe or total loss of their residual low-frequency hearing, test scores for correctly identifying certain spoken words and phrases improved from 12 percent to 54 percent, and from 14 percent to 35 percent, respectively. Study participants' hearing was assessed every few months.

Researchers' report that adverse events with the device, which typically costs about $30,000 and involves an operation lasting less than an hour to install, were relatively rare and consisted primarily of mild postoperative dizziness that quickly went away, and ringing sounds in the ear that also subsided after device activation.

INFORMATION:

Funding support for the nearly four-year-long study was provided by Cochlear Americas of Centennial, Colo., the manufacturer of the Cochlear Nucleus Hybrid implant device used in the study. Roland has served on advisory boards to both Cochlear Americas and Advanced Bionics of Valencia, Calif., another cochlear implant manufacturer. Besides Roland, other researchers involved in this study were Bruce Gantz, MD, at the University of Iowa in Iowa City; Susan Waltzman, PhD, also of NYU Langone; and Aaron Parkinson, PhD, at the University of Washington in Seattle.

Other study sites included the Center for Hearing & Balance in Chesterfield, Mo.; Hearts for Hearing in Oklahoma City; Mayo Clinic in Rochester, Minn.; Midwest Ear Institute in Kansas City, Mo.; Northwestern University in Chicago; Ohio State University in Columbus; Rocky Mountain Ear Center in Englewood, Colo.; and the University of Cincinnati in Ohio.

For more information, go to: http://nyulangone.org/doctors/1962445411/j-thomas-roland-jr http://onlinelibrary.wiley.com/doi/10.1002/lary.25451/full http://www.cochlear.com/wps/wcm/connect/intl/home

Media Contact: David March
Phone: 212-404-3528
david.march@nyumc.org



ELSE PRESS RELEASES FROM THIS DATE:

Doctor warns about lead poisoning risk from recycling older electronic equipment

2015-07-28
The disposal and recycling of electronic devices has increased exposure to lead and other toxicants and created "an emerging health concern," according to a pediatrician who directs the Environmental Health and Lead Clinic at Cincinnati Children's Hospital Medical Center. In a recent Morbidity and Mortality Weekly Report, published by the Centers for Disease Control, Dr. Nick Newman reports on two children, ages 1 and 2, whose father worked at an e-scrap recycling company crushing cathode ray tubes (CRTs). CRTs, made from leaded glass, were commonly used in televisions ...

Cancer healthcare disparities exist in the LGBTQ community, say Moffitt researchers

2015-07-28
TAMPA, Fla. - The Lesbian, Gay, Bisexual, Transgender/Transsexual, Queer/Questioning (LGBTQ) community is a growing and medically-underserved minority population in the United States, with 3 to 12 percent of the population estimated to identify as LGBTQ. Moffitt Cancer Center researchers published one of the first articles that describe the current knowledge about cancers that may disproportionately affect the LGBTQ community, and also offered suggestions for improving their healthcare. LGBTQ community deals with significant economic and health disparities. Gay and lesbian ...

New therapy delivers long-term relief for chronic back, leg pain, study finds

2015-07-28
Chicago - Chronic back and leg pain sufferers in search of better pain relief options may have a new choice. According to a study published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®), patients who received a novel high frequency form of spinal cord stimulation (SCS) therapy experienced significantly greater, long-term relief for both chronic back and leg pain, when compared to a traditional low frequency form of SCS therapy. "This is the first long-term study to compare the ...

Practice doesn't always make perfect (depending on your brain)

2015-07-28
This news release is available in French. How do you get to Carnegie Hall? New research on the brain's capacity to learn suggests there's more to it than the adage that "practise makes perfect." A music-training study by scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and colleagues in Germany found evidence to distinguish the parts of the brain that account for individual talent from the parts that are activated through training. The research involved brain imaging studies of 15 young adults with little or no musical ...

National study of deep brain stimulation for depression fails to demonstrate efficacy

2015-07-28
Philadelphia, PA, July 28, 2015 - Depression is a leading cause of disability worldwide, and treatment-resistant symptoms of depression have a terrible personal and societal cost. They can devastate lives, careers, and families. Some severely ill patients may be unable to attend to even the basic elements of self-care, while others attempt or complete suicide. Because of the clinical urgency, deep brain stimulation (DBS) treatments for depression have been developed over the past 15 years. These treatments require surgery to make a small hole in the skull through which ...

Hormones influence unethical behavior

2015-07-28
AUSTIN, Texas -- Hormones play a two-part role in encouraging and reinforcing cheating and other unethical behavior, according to research from Harvard University and The University of Texas at Austin. With cheating scandals a persistent threat on college campuses and financial fraud costing businesses more than $3.7 trillion annually, UT Austin and Harvard researchers looked to hormones for more answers, specifically the reproductive hormone testosterone and the stress hormone cortisol. According to the study, the endocrine system plays a dual role in unethical acts. ...

Illuminating mechanisms of repetitive thinking

2015-07-28
The ability to engage in mental time travel -- to delve back into past events or imagine future outcomes -- is a unique and central part of the human experience. And yet this very ability can have detrimental consequences for both physical and mental well-being when it becomes repetitive and uncontrolled. A special series of articles in the July 2015 issue of Clinical Psychological Science (CPS) investigates this kind of repetitive thinking, exploring the core psychological processes that underlie maladaptive thought processes like worry and rumination. The series highlights ...

Race & institutional factors play an important role in pharmacogenomic trial participation

2015-07-28
TAMPA, Fla. - Cancer therapy has evolved from a "one-size-fits-all" type of treatment plan to a personalized approach based on a patient's type of cancer, the protein and genetic markers found in their tumors and their response to therapy. Important aspects of the personalized approach are pharmacogenomic studies that analyze associations between genetic variations and patient drug responses. Moffitt Cancer Center researchers have published a study in the Journal of the National Cancer Institute that analyzed the participation rate of patients in pharmacogenomic trials. ...

Study finds unexpected biases against teen girls' leadership

2015-07-28
CAMBRIDGE, Mass.-- Making Caring Common (MCC), a project of the Harvard Graduate School of Education, today released new research that suggests that many teen boys and teen girls--and some of their parents--have biases against teen girls as leaders. These biases could be powerful barriers to leadership for a generation of teen girls with historically high levels of education who are key to closing our nation's gender gap in leadership. The report also suggests that much can be done to prevent and reduce gender biases in children. Titled "Leaning Out: Teen Girls and Gender ...

Ewing's sarcoma: A dangerous liaison

2015-07-28
Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich have elucidated at the molecular level how an otherwise innocuous inherited mutation that is quite common in European populations interacts with a spontaneous somatic mutation to promote the development of Ewing's sarcoma. Ewing's sarcoma is an aggressive bone cancer that occurs primarily in children, adolescents and young adults. The tumor cells are characterized by a single spontaneous 'driver mutation', which results in formation of the oncogenic fusion gene EWSR1-FLI1. Its protein product EWSR1-FLI1, ...

LAST 30 PRESS RELEASES:

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

Three-year study of young stars with NASA’s Hubble enters new chapter

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

Is it the school, or the students?

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Music: Song lyrics have become simpler and more repetitive since 1980

Environment: More than half of Colorado River’s water used to irrigate crops

When inequality is more than “skin-deep”: Social status leaves traces in the epigenome of spotted hyenas in Tanzania

Study explores the future of at-home cancer treatment

First performance standards published to measure the effectiveness of lifestyle medicine treatments

To keep volunteers, connect them

Suppressing boredom at work hurts future productivity, study shows

Older brain cells linger unexpectedly before their death

Clear shift in arterial diseases in diabetes

Celebrating half a century of pioneering excellence: EBMT marks its 50th anniversary

Ancient DNA reveals the appearance of a 6th century Chinese emperor

DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Perspectives of oncologists on the ethical implications of using AI for cancer care

Industry payments to US physicians by specialty and product type

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

COVID-19 antibody discovery could explain long COVID

Wild plants face viral surprise

Storing electrons from hydrogen for clean chemical reactions

Unlocking how to use mRNA to target Alzheimer’s disease

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research

Going ‘back to the future’ to forecast the fate of a dead Florida coral reef

[Press-News.org] Early evidence suggests hybrid cochlear implants may benefit millions with common form of hearing loss
Multicenter study led by NYU Langone Medical Center shows that device leads to major improvements in hearing and speech recognition